| (A) Criteria for potentially life-threatening conditions |
| Hemorrhagic disorders Hypertensive disorders |
| Abruptio placentae Severe preeclampsia |
| Accreta/increta/percreta placenta Eclampsia |
| Ectopic pregnancy Severe hypertension |
| Postpartum Hemorrhage Hypertensive encephalopathy |
| Ruptured uterus HELLP syndrome |
| Other systemic disorders Severe Management Indicators |
| Endometritis Blood transfusion |
| Pulmonary edema Central venous access |
| Respiratory failure Hysterectomy |
| Seizures ICU admission |
| Sepsis Prolonged hospital stay (>7 postpartum days) |
| Shock Non-anesthetic Intubation |
| Thrombocytopenia <100.000 Return to operating room |
| Thyroid crisis Surgical intervention |
| (B) Criteria for maternal near miss criteria |
| Clinical criteria |
| Acute cyanosis Loss of consciousness lasting ≥12 hours |
| Gasping Loss of consciousness AND absence of pulse/heart |
| beat |
| Respiratory rate >40 or <6/min Stroke |
| Shock Uncontrollable fit/total paralysis |
| Oliguria non-responsive to fluids or diuretics Jaundice in the presence of pre-eclampsia |
| Clotting failure |
| Laboratory-based criteria |
| Oxygen saturation <90% for ≥60 minutes pH <7.1 |
| PaO2/FiO2 <200 mmHg Lactate >5 mmol/L |
| Creatinine ≥300 mmol/l or ≥3.5 mg/dl Acute thrombocytopenia (<50 000 platelets) |
| Bilirubin>100 mmol/l or > 6.0 mg/dl Loss of consciousness AND the presence of glucose |
| and ketoacidosis in urine |
| Management-based criteria |
| Use of continuous vasoactive drugs Intubation and ventilation for ≥60 minutes |
| not related to anesthesia |
| Hysterectomy following infection/hemorrhage Dialysis for acute renal failure |
| Transfusion of ≥5 units of red cell transfusion Cardio-pulmonary resuscitation (CPR) |
